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In recent years, impaired fertility and endometrium related diseases are increased. Many evidences
suggest that environmental pollution might be considered a risk factor for endometrial physiopathology.
Among environmental pollutants, endocrine disrupting chemicals (EDCs) act on endocrine system,
causing hormonal imbalance which, in turn, leads to female and male reproductive dysfunctions. In this
work, we studied the effects of triclosan (TCL) and bisphenol A (BPA), two widespread EDCs, on human
endometrial stromal cells (ESCs), derived from endometrial biopsies from woman not affected by
endometriosis. Cell proliferation, cell cycle, migration and decidualization mechanisms were investi-
gated. Treatments have been performed with both the EDCs separately or in presence and in absence of
progesterone used as decidualization stimulus. Both TCL and BPA did not affect cell proliferation, but they
arrested ESCs at G2/M phase of cell cycle enhancing cell migration. TCL and BPA also increased gene
expression and protein levels of some decidualization markers, such as insulin growth factor binding
protein 1 (IGFBP1) and prolactin (PRL), amplifying the effect of progesterone alone. All together, our data
strongly suggest that TCL and BPA might alter human endometrium physiology so affecting fertility and
pregnancy outcome.
© 2015 Elsevier Ireland Ltd. All rights reserved.1. Introduction
Human endometrium undergoes to morphological and func-
tional changes required for a physiological reproduction. Most of
these modiﬁcations are regulated by the cyclic equilibrium of es-
trogen and progesterone levels (Martin, 1980; Clarke and
Sutherland, 1990). Brieﬂy, when estrogen levels increase endome-
trial cells begin to proliferate (proliferative phase) (Gellersen and
Brosens, 2003; Huhtinen et al., 2012) while when progesterone
levels are predominant, stromal endometrial cells differentiate into
decidual cells (secretive phase) (Johansson and Wide, 1969;
Guerrero et al., 1975; Zhang et al., 1994). The termndocrine Disruptors of Inter-
31, Naples, Italy.
rved.“decidualization” refers to the speciﬁc transformation of the stro-
mal compartment of endometrium necessary to accommodate
pregnancy (Gellersen and Brosens, 2014; Paule et al., 2010). Dif-
ferentiation of stromal cells, indeed, represents the complex initial
stage involved in the establishment of a successful pregnancy. So,
impaired decidualization causes infertility because the uterus is not
able to allow blastocyst implantation and decreases the endome-
trial receptivity of high quality embryos (Salker et al., 2010, 2012;
Gellersen and Brosens, 2014). As a consequence, it is related to
implantation and pregnancy failures (Strowitzki et al., 2006; Salker
et al., 2011; Weimar et al., 2012).
Age, genetics, diet and environmental pollutants are considered
the main risk factors for the onset of endometrial diseases such as
endometriosis, endometrial cancer or altered decidualization and
abnormal menstrual cycle (Modugno et al., 2005; Vercellini et al.,
2014; Signorile et al., 2010). In this regard, many evidences
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endocrine disruptor chemicals (EDCs) may be responsible for
endometrial-linked diseases (Cobellis et al., 2003; Kabbarah et al.,
2005; Missmer et al., 2004). EDCs act both on reproductive and
non-reproductive systems by mimicking the endogenous hor-
mones essential for the correct physiology of the organism
(Diamanti-Kandarakis et al., 2009). Bisphenol A (BPA) and Triclosan
(TCL) are well known EDCs, widely used in plastic additives, food
industry and personal care products (Rochester, 2013; Rodricks
et al., 2010). They accumulate as contaminants in rivers, lakes,
seas, groundwater and soil and have been found also in drinking
water and food (Fang et al., 2010; Kang et al., 2006; Errico et al.,
2014). Furthermore, EDCs concentration in human tissues results
increased due to their bioaccumulation through the food chain
(Muncke, 2009; Dann and Hontela, 2011). In fact, elevated con-
centrations of BPA or TCL have been reported in human breast milk,
amniotic liquid, blood and urine (Calafat et al., 2008; Dayan, 2007;
Henry and Fair, 2013; Nicolucci et al., 2013). Epidemiological
studies demonstrated a relation between plasmatic and urine levels
of EDCs and the onset of menarche, endometriosis, miscarriages
and endometrial cancer (Akesson et al., 2008; Hiroi et al., 2004;
Sugiura-Ogasawara et al., 2005). In rats, pre-natal exposure to
BPA caused endometriosis-like phenotype in F1 generation
(Signorile et al., 2010). Moreover, BPA has been found to affect in
mice the placenta patho-physiology and the age of puberty and to
stimulate proliferation of endometrial cancer cells (Gertz et al.,
2012; Lee et al., 2005; Yang et al., 2014). Clinical studies reported
that BPA is associated with miscarriages, decreased blastocyst for-
mation and implantation failure (Sugiura-Ogasawara et al., 2005;
Ehrlich et al., 2012a; Ehrilch et al., 2012b). Recently, our group
demonstrated in human children, that BPA could also affect
metabolic pathways, lipogenesis and insulin production (Menale
et al., 2015). On the contrary, to date no ﬁndings have been re-
ported in literature regarding the relation between TCL and endo-
metrial pathophysiology. However, it has been demonstrated that
TCL exerts both estrogen and anti-estrogen activity in vitro and it
may be considered as a risk factor for estrogen-related cancer (Ahn
et al., 2008; Gee et al., 2008). On the basis of these considerations,
in this study we analyzed the effects of TCL and BPA on primary
human stromal endometrial cells (ESCs), investigating on cellular
proliferation, cell migration and decidualization, three mechanisms
strictly linked each others (Petrie et al., 2009; Weimar et al., 2013).
ESCs represent a useful cellular model for the analysis of placenta
formation (Zhu et al., 2014), since they are able to differentiate
in vitro under decidualization stimuli, such as progestins and cyclic
adenosine monophosphate (cAMP) analogs (Telgmann et al., 1997;
Hess et al., 2007). Herewe investigated the ability of TCL and BPA to
alter the physiological program of endometrium. To this aim in vitro
experiments have been carried out using different concentrations
of TCL or BPA on ESCs both undifferentiated or undergone to
decidualization.
2. Materials and methods
2.1. Isolation and culture of ESCs
Endometrial tissueswere obtained during gynecological surgery
from patients during the proliferative phase of menstrual cycle.
Patients were selected for age and for absence of other pathologies
linked to endometrium (Table 1). Stromal cells were isolated from a
total of 8 samples and different experiments were performed as
reported in Table 1. Informed consensus was obtained before col-
lecting the samples. Histological examinations revealed that all
endometria were healthy. Isolation of endometrial stromal cells
was performed as described by Ryan et al. (1994). Brieﬂy,endometrium samples were minced and digested at 37 C for 1 h
with 2 mg/mL collagenase solution (Sigma Aldrich, St Louis, MO),
centrifuged and rinsed with PBS. To remove cellular debris and
undigested tissue, the digested tissue was ﬁltered through cell
strainers 100 mm and 70 mm in pore diameter, and ﬁnally with
40 mm cell strainers in pore diameter. The latter retained epithelial
cells, while stromal cells passed through. PBS containing stromal
cells was centrifuged at 800 g for 5 min, cells were resuspended in
M199 red phenol-free medium (Gibco, UK), supplemented with
10% dextran-coated charcoal FBS (Gibco), 10 nM Estradiol (Sigma),
1X Insulin/Transferrin (Sigma) and antibiotics, cultivated in cell
culture dishes in an humidiﬁed incubator with 5% CO2 at 37 C.
When 80% conﬂuence was reached, the cells were enzimatically
detached with 0.25% trypsin/EDTA (Euroclone, Milan, Italy) and
propagate in culture or frozen. Cells between passage 2 and 8 were
used for all the experiments. All the experiments were performed
in triplicate.
2.2. Immunoﬂuorescence
The purity of ESCs was assessed by immunoﬂuorescence for
vimentin (Santa Cruz Biotechnology, Santa Cruz, CA) and cytoker-
atin (Santa Cruz) antibodies. 2  104 cells per well were plated in
24-well plate. After cell attachment, cells were ﬁxed for 10minwith
ice-cold methanol, washed in PBS, blocked with 5% goat normal
serum (Santa Cruz) and incubated overnight at 4 C with vimentin
or cytokeratin. Then, Alexa ﬂuor 488 (Invitrogen Carlsbad, CA), 1 h
at RT, was used for detection in ﬂuorescence. Cell nuclei were
stained with 0.5 mg H€oechst (Invitrogen). Images were randomly
taken with an inverted ﬂuorescence microscope (Leica Micro-
system, Germany).
2.3. Chemicals and treatment
Triclosan (TCL) (Cat Number. PHR1338), Bisphenol A (BPA) (Cat
Number. 239658), Progesterone (Pr) (Cat Number. P8783) and
Mifepristone (Cat Number. M8046) were purchased from Sigma
Aldrich and separately dissolved in ethanol. Chemicals were diluted
in complete M199 red phenol-free medium (Gibco 11043-023) and
were used for undifferentiated ESCs at the following concentration:
TCL or BPA at 105 M, 108 M, 1011 M.
Treatments were done for 24 h, 48 h, 72 h as indicated in the
appropriate sections. Cells treatedwith vehicle only (ethanol 0.01%)
were used as control. The same treatments on ESCs were also
performed after a 24 h Pr pretreatment (106 M) in order to trigger
ESCs decidualization.
2.4. In vitro decidualization
Conﬂuent ESCs were starved with M199 phenol red freewith 2%
FBS for 24 h and treated for ten day with 106 M Pr. The medium
was replaced every two days. We chose to use progesterone to
induce decidualization instead of Br-AMPc (bromo-cyclic adeno-
sine monophosphate cAMP) since it is the physiological stimulus
that in vivo triggers the decidualization cascade. Then, cells were
ﬁxed with formaldehyde 3.7% for 10 min and washed with PBS for
the images observation.
2.5. Crystal violet
2  104 ESCs were plated in 24 multiwell to evaluate the effects
of TCL or BPA on cell proliferation. 24 h post-seeding, cells were
serum deprived (FBS 1%) for 24 h and then treated for additional
48 h with TCL or BPA (105 M, 108 M, 1011 M). Then, cells were
ﬁxed with formaldehyde 3.7% for 10 min, washed with PBS and
Table 1
Patients used for the experiments.
Case no. Age Cycle phase Intervention Cell culture Crystal violet FACS analysis qPCR ELISA Migration
1 38 Proliferative Hysterectomy X X X X X X
2 49 Proliferative Hysterectomy X X
3 40 Proliferative Hysterectomy X X X X X X
4 49 Proliferative Hysterectomy X X X X
5 44 Proliferative Hysterectomy X X X
6 46 Proliferative Endometrial ablation X X X
7 49 Proliferative Operative hysteroscopy X X X
8 35 Proliferative Multiple myomectomy X X X X X X
Table 2
Gene ampliﬁed by qPCR and sequences of the primer used for their ampliﬁcation.
Gene Primer sequence
IGFBP1 Forward CTATGATGGCTCGAAGGCTC
Reverse TTCTTGTTGCAGTTTGGCAG
LEFTY Forward AGCCAGAGCTTCCGAGAG
Reverse CTCCATGCCGAACACCAG
IL-6 Forward GCTGCAGGCACAGAACCA
Reverse GCTGCGCAGAATGAGATGAG
PRL Forward TCTCGCCTTTCTGCTTATTATAACC
Reverse GATTCGGCACTTCAGGAGCTT
MMP2 Forward TTGATGGCATCGCTCAGATC
Reverse TGTCACGTGGCGTCACAGT
MMP3 Forward GAGGCATCCACACCCTAGGTT
Reverse ATCAGAAATGGCTGCATCGAT
MPP11 Forward CTTCCGAGGCAGGGACTACT
Reverse AGAAGTCAGGACCCACGAGA
TIMP2 Forward CCAAGCAGGAGTTTCTCGAC
Reverse GACCCATGGGATGAGTGTTT
MMP14 Forward TCAAGGAGCGCTGGTTCTG
Reverse AGGGACGCCTCATCAAACAC
MMP9 Forward TGGGGGGCAACTCGGC
Reverse GGAATGATCTAAGCCCAG
TIMP1 Forward CTGTTGTTGCTGTGGCTGATA
Reverse CCGTCCACAAGCAATGAGT
TIMP3 Forward ATGGTGTAGACCAGCGTGC
Reverse AGGACGCCTTCTGCAACTC
GAPDH Forward CAAGGCTGTGGGCAAGGT
Reverse GGAAGGCCATGCCAGTGA
M. Forte et al. / Molecular and Cellular Endocrinology 422 (2016) 74e8376stained with 0.1% crystal violet (Sigma Aldrich) for 10 min. After
washing with PBS, acetic acid 10% was used for dissolve crystal
violet and optical densities (OD) values at 595 nmwere read with a
microplate reader.
2.6. FACS analysis
ESCs distribution in cell cycle phases was analyzed by ﬂow cit-
ometry. 24 h after serum starvation (FBS 1%), cells were treated for
48 h with TCL or BPA (105 M, 108 M, 1011 M). Then, cells were
washed with PBS, centrifuged for 5 min at 400 rpm and ﬁxed with
70% Ethanol. Pellet was resuspended in PBS and incubated for
30 min at 37 C with 100 mg/mL RNAse (Sigma Aldrich) followed by
20 mg/mL propidium iodide (Sigma Aldrich) incubation for 30 min
at 4 C in the dark. Flow citometry was performed using a FACS-
can™ ﬂow cytometry system (Becton Dickinson, San Jose, CA). For
each sample, 5  104 events were registered and cell percentage in
each phase of cell cycle was calculated.
2.7. RNA extraction and qPCR
Using Trizol, (Life Technologies) RNA from ESCs either treated
for 24, 48 and 72 h with TCL or BPA alone (105 M, 108 M, 1011 M)
or pre-treated for 24 h with Pr (Pr þ TCL, Pr þ BPA) was extracted.
Before quantiﬁcation DNA residues were depleted using DNAseI
(Life Technologies). RNA quality was assessed using Experion sys-
tem (BioRad). For qPCR assays, from each sample 500 ng of total
RNA were retrotranscribed using the High Capacity cDNA Reverse
Transcription Kit (Applied Biosystems). qPCR was performed by
means of a 7900 HT Real Time PCR (Life Technologies). Primers
(Table 2) of genes investigated (IGFBP1, LEFTY, IL-6, PRL, MMP2,
MMP3, MPP11, TIMP2, MMP14, MMP9, TIMP1, TIMP3) were designed
using Primer express 3.0 (Applied Biosystems) and the sequences in
GenBank (http://www.ncbi.nlm.nih.gov/genbank). The amount of
cDNA target was calculated using the cycle threshold (Ct) and
expressed as mean of the 2DDCt method (Livak and Schmittgen,
2001) using GAPDH as housekeeping gene.
2.8. Migration assay
Cells were treated for 48 h with TCL or BPA (108 M) alone or
after a 24 h pre-treatment with Pr (106 M). Then ESCs were
trypsinized and allowed to attach in the upper sides of transwell.
Cells migration assays were performed using 8 mm pores transwell
inserts (BD, Falcon) for a time (24 h) shorter than doubling time of
ESCs. Non-migrated cells on the upper side of the transwell were
removed by a cotton swab. Migrated cells, attached to the inner side
of the transwell, were ﬁxed with formaldehyde 3.7% and stained
with 0.1% crystal violet. Cells were counted by two observers in a
double blind method (V.M., M.F.) using Image J plugin cell counter
(http://imagej.nih.gov/ij/). For each transwell, 5 images (10
enlargement) were taken.2.9. ELISA
To assess IGFBP1 and PRL secretion, ELISA assays were per-
formed using speciﬁc kits (Abcam, Cambridge, UK) and according to
the manufacturer's instructions. Brieﬂy, 1  106 cells were seeded
in 100 mm culture dish and treated with BPA or TCL (108 M) for
48 h alone or pre-treated for 24 h with Pr (106 M). IGFBP1 and PRL
levels were also evaluated in differentiated cells, at the end of the
experiment (10th day of treatment) and in ESCs treated with Pr
106 M, TCL or BPA 108 in combination with the Pr receptor
modulator Mifepristone (106 M) (Supplementary data). Then, cell
culture supernatants were centrifuged for debris removal for the
assay. Readings were performed at 450 nm and the values were
converted in protein concentration, after generating a calibration
curve using appropriate standards.2.10. Statistical analysis
Statistical analysis was performed using Graph Pad Prism 5.0
(GraphPad Software, San Diego, CA, USA). For each analysis
means ± SE of three independent experiments are reported. Sig-
niﬁcance of multiple treatments was evaluated using the One Way
ANOVAwith Bonferroni post hoc, and P < 0.05 was considered to be
statistically signiﬁcant.
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3.1. ESCs proliferation and cell cycle phases
In order to evaluate the ESCs purity, we ﬁrst analyzed by
immunoﬂuorescence the presence of vimentin, a speciﬁc marker
for endometrial stromal cells (Fig. S1). In vitro decidualization was
induced treating ESCs cells with Pr (106 M) and it was completed
in 10 days (Fig. S2).
Crystal violet assay was performed to analyze the effects of EDCs
on endometrial stromal cells. ESCs treated for 48 h with different
concentrations of TCL or BPA (105 M, 108 M, 1011 M) did not
show signiﬁcant changes in proliferation (Fig. 1A and B) compared
to the control (vehicle 0.01%).
To analyze the cell cycle perturbation induced by EDCs, ESCs
exposed for 48 h to TCL or BPA were subjected to cytoﬂuorimetry
analysis. Fig. 2 shows representative pictures of cell cycle distri-
bution under the different experimental conditions. 105 M TCL
treatment did not perturb cell cycle phase distribution (Fig. 2A),
while decreasing TCL amount (108 M and 1011 M) signiﬁcantly
induced the switch in G2/M phase of cell cycle (Fig. 2B and C), whit
a concomitant decrease of G0/G1 cell fraction. Similarly, BPA
treatments (108 M and 1011 M) increased G2/M and decreased
G0/G1 fraction (Fig. 2E and F). No variations were observed after the
treatment with BPA at 105 M (Fig. 2D).
Histograms (Fig. 2H and I) summarize the percentage distribu-
tions of the cells in each cycle phase for each experimental
condition.3.2. Gene analysis of decidualization markers
To understand if EDCs could affect the transformation of stromal
endometrium we assessed if TCL and BPA were able to deregulate
genes involved in decidualization such as IGFBP1, LEFTY, PRL, IL6. To
this aim the expression of these genes was analyzed by means of
qPCR after 24 h (Panel A), 48 h (Panel B) or 72 h (Panel C) of TCL or
BPA exposure. Furthermore the effect of both EDCs on gene
expression was also analyzed in ESCs pre-treated for 24 h with
106 M Pr before adding TCL or BPA (Prþ TCL; Prþ BPA), and in the
corresponding ESCs control treated with Pr alone. Fig. 3 refers to
the expression of IGFBP1, Fig. 4 to the expression of LEFTY, Fig. 5 to
the expression of PRL and Fig. S3 to the expression of IL6. We did not
observe any variation after 24 h of exposure in IGFBP1mRNA levels
(Fig. 3A). In contrast, TCL increased IGFBP1 expression after 48 h at
all the concentrations used but only at 108 M and 1011 M in ESCsFig. 1. TCL and BPA effects on ESCs Proliferation. ESCs treated for 48 h with TCL (A) and B
detected in treated cells compared to control.pre-treated with Pr (Fig. 3B). After 72 h TCL signiﬁcantly affected
IGFBP1 gene expression at 105 M and 108 M in both ESCs treated
with TCL alone or pre-treated with Pr (Fig. 3C). IGFBP1 resulted
similarly modulated by BPA 108 M and 1011 M and by BPAþ Pr at
108 M after 48 and 72 h of exposure (Fig. 3B and C). Time course
analysis for LEFTY revealed no change in gene levels after 24 h of
treatment (Fig. 4A). 108 M and 1011 M TCL treatment of ESCs
revealed an increased expression of LEFTY after 48 and 72 h, while
in ESCs pre-treatedwith Pr it was effective at 108 M (Fig. 4B and C).
BPA affected LEFTY expression only at 108 M after 48 h of treat-
ment but no additive effects were detected with Pr (Fig. 4B). PRL
expression did not change after 24 h of treatment (Fig. 5A). TCL
increased PRL expression after 48 h of treatment at 108 M and
1011 M (Fig. 5B). At 72 h the effect persisted only at 108 M
(Fig. 5C). PRL mRNA levels resulted increased after BPA 108 M
treatment at 48 h and at 108 M and 1011 M after 72 h (Fig. 5B and
C). In this case, we observed a synergistic effect in ESCs pre-treated
with Pr and treatedwith BPA 108M after 72 h of exposure (Fig. 5C).
We did not observe any difference in the expression levels of IL-
6 in ESCs treated cells compared to control (Fig. S3AeC).3.3. ESCs migration analysis
To better elucidate if BPA or TCL were able to induce ESCs
migration, we analyzed this process investigating by qPCR the
expression of genes involved in migration process (Fig. 6) and
performing a migration assay after 48 h of treatment on ESCs
(Fig. 7). Among metalloprotease genes (MMPs) analyzed the mRNA
levels ofMMP2 (Fig. 6A),MMP11 (Fig. 6D) andMMP14 (Fig. 6E) were
unaffected by both treatment with TCL or BPA. However MMP14
resulted positively regulated by Pr (Fig. 6E). MMP3 mRNA levels
increased after TCL treatment with a signiﬁcant increase directly
linked toTCL concentrations (105 M and 108 M) (Fig. 6B). Pr alone
down-regulated MMP3 expression (Fig. 6B), while Pr in combina-
tion with TCL (105 M and 108 M) determined increased expres-
sion of MMP3 compared to Pr treated cells (Fig. 6B). BPA affected
differently the expression ofMMP3 since it resulted effective only at
108 M (Fig. 6B). TCL (108 M) and BPA (105 M and 108 M) both
increased the expression of MMP9 that resulted up-regulated also
in cells treated with Pr alone or in combination with TCL (Fig. 6C).
Regarding the expression of tissue inhibitor of metalloproteinase
(TIMP), only TCL slightly decreased TIMP1 (Fig. 6F) and dramatically
down-regulated TIMP2, alone or administered after Pr treatment
(Fig. 6G). TIMP3, instead, resulted down-regulated in ESCs treated
with TCL, BPA (105 M) and Pr (Fig. 6H).PA (B) were analyzed by crystal violet test. No variations in optical density (OD) were
Fig. 2. Cell cycle distribution of ESCs cells after TCL and BPA exposure. Representative histograms (AeG) and relative data summary (H, I) shown an increased percent of cells in
G2/M after 108 M and 1011 M treatment with TCL (B, C) and BPA (E, F), with a subsequent decreasing in G0/G1 phase. Results were analyzed comparing treated (AeF) and
untreated cells (G). Data represent the mean ± SE of three experiments. **P < 0.01 related to control group.
Fig. 3. Gene expression of IGFBP1 after treatment with TCL or BPA. ESCs cells were treated for 24 h (Panel A), 48 h (Panel B) and 72 h (Panel C) with TCL or BPA alone (105 M,
108 M, 1011 M) or after pre-treatment for 24 h with 106 M Pr (þ). Control cells (Ctrl) were treated with vehicle only. IGFBP1 mRNA levels were normalized using GAPDH as
housekeeping gene. a, response signiﬁcantly different than the vehicle control (P < 0.05); a, response signiﬁcantly different than the vehicle control (P < 0.01); b, response
signiﬁcantly different than Pr alone (P < 0.05).
Fig. 4. Gene expression of LEFTY after treatment with TCL or BPA. ESCs cells were treated for 24 h (Panel A), 48 h (Panel B) and 72 h (Panel C) with TCL or BPA alone (105 M,
108 M, 1011 M) or after pre-treatment for 24 h with 106 M Pr (þ). Control cells (Ctrl) were treated with vehicle only. LEFTY mRNA levels were normalized using GAPDH as
housekeeping gene. a, response signiﬁcantly different than the vehicle control (P < 0.05); a, response signiﬁcantly different than the vehicle control (P < 0.01); b, response
signiﬁcantly different than Pr alone (P < 0.05).
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modiﬁed migratory capability of ESCs, we performed a migration
assay treating ESCs at the concentration of 108 M for TCL or BPA,
that showed the highest effect on gene expression. As reported inFig. 7, TCL or BPA (108 M) as well as Pr (106 M) enhanced the
migration of ESCs cells, with the high number of migrated cells
detected in Pr treated ESCs. Moreover, the highest induction of
migration was evident in Pr þ TCL. No signiﬁcant differences were
Fig. 5. Gene expression of PRL after treatment with TCL or BPA. ESCs cells were treated for 24 h (Panel A), 48 h (Panel B) and 72 h (Panel C) with TCL or BPA alone (105 M,
108 M, 1011 M) or after pre-treatment for 24 h with 106 M Pr (þ). Control cells (Ctrl) were treated with vehicle only. PRL mRNA levels were normalized using GAPDH as
housekeeping gene. a, response signiﬁcantly different than the vehicle control (P < 0.05); a, response signiﬁcantly different than the vehicle control (P < 0.01); b, response
signiﬁcantly different than Pr alone (P < 0.05).
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3.4. IGFBP1 and PRL secretion
To verify if gene deregulation resulted in protein levels varia-
tions, we monitored the secretion of IGFBP1 and Prolactin (PRL)
after 48 h of treatment using ELISA. As shown in Fig. 8A, Pr, TCL or
BPA alone increased the amount of secreted IGFBP1. In combined
treatment, Pr þ TCL showed the highest level of IGFBP1 compared
to Prþ BPA. Also PRL levels (Fig. 8B) resulted notably increased after
treatment with Pr. PRL secretion is also enhanced by both TCL and
BPA treated cells as well as in Pr þ TCL treated cells. Conversely, no
additive action was evidenced after the treatment with Pr þ BPA,
compared to Pr treated cells. In addition, to assess if TCL or BPA
affected IGFBP-1 secretion via Pr receptor, we performed an ELISA
adding a Pr signaling modulator (Mifepristone 106 M) in ESCs
treated with TCL or BPA. As shown in Fig. S4 Mifepristone reduced
the IGFB1 secretion only in Pr treated cells, without inhibiting its
secretion in ESCs exposed to TCL or BPA 108 M.
4. Discussion
Human endometrium is a steroid-responsive tissue subjected to
cyclic regeneration involving proliferation, differentiation, break-
down and repair (Norwitz et al., 2001). During eachmenstrual cycle
the endometrium shows a short period of receptivity for successful
embryo implantation known as ‘implantation window’. This study
was aimed to ascertain the effects induced by TCL or BPA exposure
on undifferentiated ESCs and ESCs that begin their decidualization
process. TCL and BPA belong to the class of EDCs, xenobiotic com-
pounds that interfere with the molecular pathways of living or-
ganisms. It is well known that EDCs can increase or decrease the
hormone receptor activities (Diamanti-Kandarakis et al., 2009).
Several studies in animal models underline the involvement of
EDCs on the development of female reproductive system diseases
(Mouritsen et al., 2010; Semiz et al., 2008). However, little is known
about their effects on human endometrium.
In this work we simulated in vitro the physiological cycle of
endometrium and evaluated the physiological responses after
exposure to relevant environmental and serum doses of TCL or BPA.
As reported in literature, human serum BPA concentration ranges
between about 109 M and 108 M in healthy subjects and in
women with recurrent miscarriages, respectively (Takeuchi and
Tsutsumi, 2002; Zheng et al., 2012). BPA distribution in other
sources has been shown to range between 1011e107 M in surface
water and efﬂuents and between 1010e109 M in drinking water
(Michałowicz, 2014). TCL has been demonstrated to be concentrate
in human serum at 108 M (Allmyr et al., 2008), while was found in
drinking water at 1010 M (Loraine and Pettigrove, 2006) and in
surface water and efﬂuents in a range between 1013e108 M
(Bedoux et al., 2012). Hence, we decided to perform theexperiments using different concentrations of EDCs from 105 M,
usually found in occupational exposure to EDCs (Xiao et al., 2009)
to 1011 M. The concentration 108 M and 1011 M were used to
verify the low dose effects (Vandenberg et al., 2007).
We ﬁrst evaluated the responses of ESCs treated with TCL or BPA
alone for 48 h, investigating the proliferation and the cell cycle
phases distribution. Several studies reported that BPA increases cell
proliferation, but most of these studies analyzed tumorigenic or
epithelial cells, such as human endometrial cancer cells and breast
cancer cells (Soto et al., 1995; Ricupito et al., 2009; Pisapia et al.,
2012); in contrast TCL has been shown to have a dual role in
stimulating or inhibiting cell proliferation (Ahn et al., 2008). Our
results highlighted non-signiﬁcant changes in the proliferation
proﬁle. On the other hand, TCL and BPA treatments increased cell
cycle G2/M phase in ESCs, a clear signal of the beginning of the
differentiation process. Data reported in literature have shown that
stromal endometrial cells are arrested in G2/M phase after
decidualization stimuli, such as progesterone (Logan et al., 2012;
Tang et al., 2009). So, we focused our attention on the deciduali-
zation process, testing the effect of TCL or BPA on ESCs non
completely differentiated but treated for 24 h with Pr prior to start
the treatment with EDCs. Decidualization is the mechanism by
which stromal cells of endometrium prepare the uterus to
accommodate the embryo (Gellersen and Brosens, 2014).
Notwithstanding this process in not completely characterized, two
observations are already ﬁrmly established: i) the morphological
changes of stromal cells from ﬁbroblast to epithelioid phenotype
(Mannelli et al., 2014) during decidualization; and ii) the increased
levels of IGFBP-1, LEFTY and PRL, that are the main markers whose
expression increases during decidualization (Gellersen and
Brosens, 2014). During this phase, endometrial stromal cells
reprogram their cell cycle and acquire a migratory capability
needed for the establishment of contact with the trophoblast
(Logan et al., 2012).
After treatments, we analyzed the expression of the main
markers of decidualization, such as the insulin growth factor
binding protein 1 (IGFBP1), prolactin (PRL), LEFTY and the inter-
leukin 6 (IL-6). qPCR analysis showed a variable proﬁle of gene
expression after the treatment with TCL or BPA. The short time
exposure (24 h) did not produce variations in gene levels. In
contrast, TCL was found to up-regulate IGFBP1, LEFTY and PRL at 48
and 72 h. Notably, the concentration of TCL that always induced a
deregulation of these genes is 108 M. Moreover, TCL 108 M is also
able to enhance the expression of IGFB1 and LEFTY in ESCs pre-
treated with Pr. Our experiments demonstrated that BPA also
affected gene levels of decidualization markers. Its effect was less
signiﬁcant if compared to TCL. As example, BPA 108 M enhanced
the up-regulation induced by Pr only after 48 h for IGFBP1 and 72 h
for PRL. Hence, we decided to verify with ELISA assay if the gene
expression of IGFBP1 and PRL resulted in an increased secretion of
these two proteins. We performed the assay treating the cells with
Fig. 6. Gene expression of genes involved in cell migration. ESCs cells were treated for 48 h with TCL and BPA alone (105 M, 108 M, 1011 M) or after pre-treatment for 24 h with
106 M Pr (þ). Control cells (Ctrl) were treated with vehicle only.MMP2 (A),MMP3 (B),MMP9 (C),MMP11 (D),MMP14 (E), TIMP1 (F), TIMP2 (G), TIMP3 (H) relative mRNA levels were
normalized using GAPDH as housekeeping gene. a, response signiﬁcantly different than the vehicle control (P < 0.05); a, response signiﬁcantly different than the vehicle control
(P < 0.01); b, response signiﬁcantly different than Pr alone (P < 0.05).
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fects in gene expression analysis. Both EDCs analyzed increased the
secretion of IGFBP1 and PRL. In particular, TCL enhanced the
secretion of both IGFBP1 and PRL induced by Pr. Notwithstanding
our results did not show a time and a concentration dependent
effect, wemight speculate that TCL or BPA could mimic the effect ofPr, activating the AMPc-Protein Kinase A pathway. Interestingly,
Aghajanova and Giudice (2011) also investigated the effects of BPA
on human endometrial stromal cells after 48 h of treatment,
although using concentration of BPA much higher (from 104 M to
5  106 M) compared to the concentration used in our study. In
particular they demonstrated that BPA is able to up-regulated
Fig. 7. Migration assay. Representative images of migration assay after TCL or BPA treatment and quantitative evaluation. Pr (106 M), TCL and BPA (108 M), enhanced migration of
ESCs. ESCs pre-treated for 24 h with Pr and treated with TCL showed the highest number of migrated cells. Scale bar: 100 mm. a, response signiﬁcantly different than the vehicle
control (P < 0.05); a, response signiﬁcantly different than the vehicle control (P < 0.01); b, response signiﬁcantly different than Pr alone (P < 0.05).
Fig. 8. IGFBP1 and PRL secretion after TCL or BPA treatment. TCL or BPA (108 M) treatment for 48 h increases the IGFBP1 production (A). TCL after 24 h of pre-treatment with Pr
(106 M) showed higher IGFBP1 levels compared to Pr cells. PRL secretion was enhanced after TCL, BPA and Pr treatment. Pre-treatment with Pr induced PRL secretion in ESCs
treated with TCL (B). a, response signiﬁcantly different than the vehicle control (P < 0.05); a, response signiﬁcantly different than the vehicle control (P < 0.01); b, response
signiﬁcantly different than Pr alone (P < 0.05); b, response signiﬁcantly different than the vehicle control (P < 0.01).
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ditive effect in ESCs pre-treated with cAMP. Moreover, they did not
ﬁnd variation at the lowest concentration tested (5  106 M) both
for IGFBP1 and PRL. In the same study, authors demonstrated that
BPA act in ESCs in a pathway that not involves estrogen receptors.
The incongruity between our results and those of Aghajanova and
Giudice can be explained surely by the different concentrations of
BPA used. Recently the concept of “low dose effects” has been
accepted as a general feature for EDCs. The concentrations used in
this study are the same previously described in the serum of
healthy subjects, both for BPA and TCL (Takeuchi and Tsutsumi,
2002; Allmyr et al., 2008). In summary, our results show that TCL
or BPA might trigger decidualization even in absence of other
decidualization stimuli. However, when progesterone is present,these mechanisms appear to be additive. Finally, we analyzed the
action of TCL or BPA on the migratory capacity of ESCs. Both EDCs,
as well as progesterone, strongly induce ESCs to migrate. Expres-
sion of genes involved in migration resulted deregulated especially
in ESCs exposed to TCL, compared to other treatments. Speciﬁcally,
108 M TCL seems to induce migration through up-regulation of
MMP3 and MMP9 and via down-regulation of TIMP1, TIMP2. The
ability to potentiate the migration induced by Pr probably involves
aMMP3-MMP9-TIMP2 dependent pathway. BPA at 108 M, instead,
induced ESCs migration via MMP3 and MMP9 without affecting
TIMP expression. Migration of cells belonging to endometrium
stromal compartment could be considered as a clear signal of dif-
ferentiation, and it has been demonstrated that expression of
metalloproteases, the keys molecules for cell migration, increases
M. Forte et al. / Molecular and Cellular Endocrinology 422 (2016) 74e8382in stromal cells during decidualization (Gellersen et al., 2010; Guo
et al., 2011).
5. Conclusions
This study strongly suggests that some EDCs act on human
stromal compartment of endometrium. Our results clearly indicate
that TCL and BPA are able to interfere with molecular pathways of
decidualization, enhancing the expression of some key molecules
involved in this process and to stimulate stromal cells cell migra-
tion. Notwithstanding the molecular pathways involved in the ac-
tion of TCL or BPA on stromal endometrial cells need further
investigations, translating this data to humans, it is possible to
speculate that exposure to TCL or BPA may be considered a risk
factor for the endometrial physiology, which in turn leads to
reproductive failure. Human are routinely exposed to BPA and TCL
but in women, by mimicking steroid hormones, EDCs may alter the
normal equilibrium in progesterone and estradiol homeostasis, so
creating a receptive uterine environment which decreases the
probability to gain a successful embryo implantation. Moreover,
our results indicated that low concentration of EDCs, might have
signiﬁcant biological effects on humans. Finally, in this study we
highlighted the deleterious effects of TCL, an EDC less known in
literature but usually found in personal care products.
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